By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

AVAX Technologies, Inc. 

4520 Main Street, Suite 930

Kansas City  Missouri  64111  U.S.A.
Phone: 816-960-1333 Fax: 816-960-1334


SEARCH JOBS


Industry
Biotechnology






Company News
AVAX Technologies, Inc. (AVXT) Announces Expansion Of Clinical Study With Autologous Ovarian Cancer Vaccine (Ovax®) 2/11/2014 10:01:21 AM
AVAX Technologies, Inc. (AVXT) Files Form 10 With SEC 2/4/2011 11:20:30 AM
AVAX Technologies, Inc. (AVXT) Closes Bridge Financing 12/17/2009 8:29:20 AM
VasoGenix Pharmaceuticals, Inc. Elects Former AVAX Technologies, Inc. (AVXT) CEO Richard P. Rainey to Its Board of Directors 2/3/2009 11:24:37 AM
AVAX Technologies, Inc. (AVXT) Announces Closing of Bridge Loan Financing 10/31/2008 11:25:39 AM
AVAX Technologies, Inc. (AVXT) Presents Results of a Dose-Response Study of MVax(R) at American Society of Clinical Oncology 6/3/2008 2:37:20 PM
AVAX Technologies, Inc. (AVXT) Announces Initiation of Clinical Study with Autologous Ovarian Cancer Vaccine (OVax(R)) 4/9/2008 7:04:47 AM
AVAX Technologies, Inc. (AVXT) Appoints Chief Medical Officer for EMEA 3/31/2008 9:02:33 AM
AVAX Technologies, Inc. (AVXT) to Present Results of Phase I-II Study of MVax(R) at 2008 Meeting of the American Society of Clinical Oncology 3/24/2008 9:29:40 AM
AVAX Technologies, Inc. (AVXT) Announces Successful Completion of Phase I / II Study of MVax(R) in Patients with Stage 3 and 4 Melanoma 12/11/2007 1:16:04 PM
1234
//-->